Speaker Spotlight: Interview
We recently sat down with Genevieve Desjardins, Associate Director, Protein Engineering at Zymeworks, and speaker at the 8th T‑Cell Engager Therapeutics Summit.
In this interview, Genevieve shares her perspective on:
- What’s needed to unlock the next wave of T‑cell engager breakthroughs
- How development strategies are evolving as the field matures
- Improving efficacy in solid tumors through CD28 co‑stimulation
Explore the Full Event Guide
- 120+ Industry Attendees
- 28+ World-Class Speakers
- 8+ Hours of Unrivalled Networking Opportunities
- 6 Deep-Dive Workshops
- 2 Brand New Parallel Conference Tracks - Discovery & Engineering and Preclinical to Clinical Translation
